Showing results (271-280 of 296) with videos related to

Sort By:
Pageof 30
Human Gene Therapy|September 25, 2003
High-level expression of cancer/testis antigen NY-ESO-1 and human granulocyte-macrophage colony-stimulating factor in dendritic cells with a bicistronic retroviral vectorR B Batchu, A M Moreno, S Szmania, et al.
British Journal of Haematology|September 21, 2001
Results of autologous stem cell transplant in multiple myeloma patients with renal failureA Badros, B Barlogie, E Siegel, et al.
British Journal of Haematology|February 13, 2001
Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor aloneK R Desikan, G Tricot, N C Munshi, et al.
Blood|April 21, 2001
High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusionsA Badros, B Barlogie, C Morris, et al.
Blood|June 17, 1998
Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myelomaG Tricot, Y Gazitt, T Leemhuis, et al.
British Journal of Haematology|October 6, 2004
A phase 2 study of two doses of bortezomib in relapsed or refractory myelomaS Jagannath, B Barlogie, J Berenson, et al.
Nature Genetics|February 1, 1996
Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemiaT Nakamura, D A Largaespada, M P Lee, et al.
Leukemia|August 7, 2009
Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myelomaB G M Durie, B Van Ness, C Ramos, et al.
Oncogene|April 12, 2011
Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cellsU-M Fagerli, K Ullrich, T Stühmer, et al.
Blood|June 14, 2000
Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalitiesR Desikan, B Barlogie, J Sawyer, et al.
Pageof 30